Flourish Research (“Flourish”), a leading multi-site clinical trial organization focused primarily on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas, announces the partnership with Valkyrie Clinical Trials (“Valkyrie”), a premier network of oncology-focused clinical research sites. Founded in 2021 by leading medical oncologist Dr. David Berz, Valkyrie provides cutting-edge cancer therapy to a highly diverse patient population and supports sponsors by furthering research in novel therapies and treatments. The company operates three sites in Los Angeles, CA, serving a network of over 200,000 cancer patients.
Read the full article: Flourish Research Establishes Meaningful Presence in Oncology with Strategic Investment in Valkyrie Clinical Trials //
Source: https://www.prnewswire.com/news-releases/flourish-research-establishes-meaningful-presence-in-oncology-with-strategic-investment-in-valkyrie-clinical-trials-302575385.html